These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2572797)

  • 1. Treatment of narcolepsy with L-tyrosine: double-blind placebo-controlled trial.
    Elwes RD; Crewes H; Chesterman LP; Summers B; Jenner P; Binnie CD; Parkes JD
    Lancet; 1989 Nov; 2(8671):1067-9. PubMed ID: 2572797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures.
    Scrima L; Hartman PG; Johnson FH; Hiller FC
    Biol Psychiatry; 1989 Aug; 26(4):331-43. PubMed ID: 2669980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy.
    Weinhold SL; Seeck-Hirschner M; Nowak A; Hallschmid M; Göder R; Baier PC
    Behav Brain Res; 2014 Apr; 262():8-13. PubMed ID: 24406723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Narcolepsy in the older adult: epidemiology, diagnosis and management.
    Chakravorty SS; Rye DB
    Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate].
    Poza-Aldea JJ
    Rev Neurol; 2009 Jan 1-15; 48(1):27-31. PubMed ID: 19145563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, double-blind, placebo-controlled, randomized, Phase 1b crossover trial comparing two doses of ulotaront with placebo in the treatment of narcolepsy-cataplexy.
    Szabo ST; Hopkins SC; Lew R; Loebel A; Roth T; Koblan KS
    Sleep Med; 2023 Jul; 107():202-211. PubMed ID: 37209427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selegeline hydrochloride treatment in narcolepsy. A double-blind, placebo-controlled study.
    Mayer G; Ewert Meier K; Hephata K
    Clin Neuropharmacol; 1995 Aug; 18(4):306-19. PubMed ID: 8665543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study.
    Lammers GJ; Arends J; Declerck AC; Ferrari MD; Schouwink G; Troost J
    Sleep; 1993 Apr; 16(3):216-20. PubMed ID: 8506453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy.
    Baier PC; Hallschmid M; Seeck-Hirschner M; Weinhold SL; Burkert S; Diessner N; Göder R; Aldenhoff JB; Hinze-Selch D
    Sleep Med; 2011 Dec; 12(10):941-6. PubMed ID: 22036605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulpiride, a D2/D3 blocker, reduces cataplexy but not REM sleep in canine narcolepsy.
    Okura M; Riehl J; Mignot E; Nishino S
    Neuropsychopharmacology; 2000 Nov; 23(5):528-38. PubMed ID: 11027918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and polygraphic effects of d.1 5 HTP on narcolepsy-cataplexy.
    Autret A; Minz M; Beillevaire T; Degos C; Cathala HP
    Biomedicine; 1977 Jul; 27(5):200-3. PubMed ID: 336110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
    Prescrire Int; 2007 Jun; 16(89):98-101. PubMed ID: 17582923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Narcolepsy: a new perspective on diagnosis and treatment].
    Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
    Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of narcolepsy with L-tyrosine.
    Mouret J; Lemoine P; Sanchez P; Robelin N; Taillard J; Canini F
    Lancet; 1988 Dec 24-31; 2(8626-8627):1458-9. PubMed ID: 2904574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selegiline in the treatment of narcolepsy.
    Hublin C; Partinen M; Heinonen EH; Puukka P; Salmi T
    Neurology; 1994 Nov; 44(11):2095-101. PubMed ID: 7969965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of modafinil and amphetamine on daytime sleepiness and cataplexy of narcoleptic dogs.
    Shelton J; Nishino S; Vaught J; Dement WC; Mignot E
    Sleep; 1995 Dec; 18(10):817-26. PubMed ID: 8746387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
    Sleep; 2002 Feb; 25(1):42-9. PubMed ID: 11833860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ritanserin improves sleep quality in narcolepsy.
    Mayer G
    Pharmacopsychiatry; 2003 Jul; 36(4):150-5. PubMed ID: 12905101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nocturnal gamma-hydroxybutyrate on sleep/waking patterns in narcolepsy-cataplexy.
    Broughton R; Mamelak M
    Can J Neurol Sci; 1980 Feb; 7(1):23-31. PubMed ID: 7388696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
    Black J; Swick T; Bogan R; Lai C; Carter LP
    Sleep Med; 2016 Aug; 24():57-62. PubMed ID: 27810187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.